Vanguard Group’s PHARMACYCLICS INC PCYC Stock Holding History

Vanguard Group’s Portfolio PCYC Stock Details PCYC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-3,920,973	Closed	-$1B	–	4230
2015 Q1	$1B	Buy	3,920,973 +294,237	+8%	+$56.8M	0.07%	325
2014 Q4	$443M	Buy	3,626,736 +106,620	+3%	+$13.6M	0.03%	597
2014 Q3	$413M	Buy	3,520,116 +46,553	+1%	+$5.31M	0.03%	582
2014 Q2	$312M	Buy	3,473,563 +72,715	+2%	+$6.82M	0.02%	744
2014 Q1	$341M	Buy	3,400,848 +158,228	+5%	+$20.6M	0.03%	659
2013 Q4	$343M	Buy	3,242,620 +36,259	+1%	+$4.4M	0.03%	611
2013 Q3	$444M	Buy	3,206,361 +12,034	+0.4%	+$1.34M	0.04%	487
2013 Q2	$254M	Buy	+3,194,327	New	+$261M	0.03%	670

Other funds holding PCYC

Credit Agricole Montrouge Cedex, France $49.3B AUM 36.45% 1-Year Est. Return

Vanguard Group's PCYC Position: Q2 2015 in Review

Vanguard Group sold out of PHARMACYCLICS INC (PCYC) in Q2 2015, closing a stake of 3,920,973 shares — an estimated $1B sold.

Vanguard Group first reported a position in PCYC in Q2 2013 and held it in 8 quarters. The position peaked at $1B in Q1 2015. 1 fund tracked by Wall St. Rank holds PCYC as of Q2 2015.

Vanguard Group reported no remaining PHARMACYCLICS INC position as of Q2 2015 after selling out during the quarter.
Vanguard Group sold 3,920,973 PHARMACYCLICS INC shares in Q2 2015, an estimated $1B.
Vanguard Group first reported a position in PHARMACYCLICS INC in Q2 2013 and held it in 8 quarters.
Vanguard Group's PHARMACYCLICS INC position peaked at $1B in Q1 2015.
1 fund tracked by Wall St. Rank held PHARMACYCLICS INC as of Q2 2015.

Based on Vanguard Group's 13F filing for Q2 2015, filed 13 Aug 2015.